The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes
Principal Investigator
Study Number
F18009
Summary
This is a multicenter, cross-sectional, cohort study which will collect contemporary sweat chloride (SC) values from approximately 5000 Cystic Fibrosis (CF) patients prescribed and currently receiving commercially approved Cystic Fibrosis transmembrane conductance regulator (CFTR) modulator therapies.
Phase
N/A
Contact
Available at the following location(s)
- Lebanon
- Manchester
View more details at ClinicalTrials.gov
Do you need help with some of the labels on this page?
Read our glossary of terms